BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23889318)

  • 1. Emerging therapeutic aspects in oncology.
    Macewan DJ
    Br J Pharmacol; 2013 Aug; 169(8):1647-51. PubMed ID: 23889318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.
    Curtin NJ
    Br J Pharmacol; 2013 Aug; 169(8):1745-65. PubMed ID: 23682925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting survival pathways in chronic myeloid leukaemia stem cells.
    Sinclair A; Latif AL; Holyoake TL
    Br J Pharmacol; 2013 Aug; 169(8):1693-707. PubMed ID: 23517124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Themed section: endothelin.
    Davenport AP; Barton M
    Br J Pharmacol; 2013 Jan; 168(2):279-82. PubMed ID: 23278331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cancer chemotherapy; past, present and future--from the aspect of fundamental studies].
    Tukagoshi S
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1398-403. PubMed ID: 14584271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of Ras in drug resistance in cancer.
    Healy FM; Prior IA; MacEwan DJ
    Br J Pharmacol; 2022 Jun; 179(12):2844-2867. PubMed ID: 33634485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport Barriers and Oncophysics in Cancer Treatment.
    Nizzero S; Ziemys A; Ferrari M
    Trends Cancer; 2018 Apr; 4(4):277-280. PubMed ID: 29606312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The background to this themed issue on neuropeptides.
    Keeble J
    Br J Pharmacol; 2013 Dec; 170(7):1277-8. PubMed ID: 24236898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of anthocyanins on the prevention and treatment of cancer.
    Lin BW; Gong CC; Song HF; Cui YY
    Br J Pharmacol; 2017 Jun; 174(11):1226-1243. PubMed ID: 27646173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The key role of oncopharmacology in therapeutic management, from common to rare cancers: A literature review.
    Louveau B; Jouenne F; Kaguelidou F; Landras A; Goldwirt L; Mourah S
    Therapie; 2020 Apr; 75(2):183-193. PubMed ID: 32173061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in apoptosis, mitochondria and drug resistance in cancer cells.
    Indran IR; Tufo G; Pervaiz S; Brenner C
    Biochim Biophys Acta; 2011 Jun; 1807(6):735-45. PubMed ID: 21453675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of novel selective-spectrum kinase inhibitors in oncology.
    Lorusso PM; Eder JP
    Expert Opin Investig Drugs; 2008 Jul; 17(7):1013-28. PubMed ID: 18549338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncology. Are Voltaire and Rousseau now wrong?
    Raghavan D
    Lancet; 1996 Dec 21-28; 348 Suppl 2():sII17. PubMed ID: 8973495
    [No Abstract]   [Full Text] [Related]  

  • 16. Cracking the mild, difficult and fiendish codes within and downstream of the EGFR to link diagnostics and therapeutics.
    Waterfield M
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):1-6. PubMed ID: 17212578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic cancer.
    Güngör C; Hofmann BT; Wolters-Eisfeld G; Bockhorn M
    Br J Pharmacol; 2014 Feb; 171(4):849-58. PubMed ID: 24024905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision medicine in pediatric oncology.
    Forrest SJ; Geoerger B; Janeway KA
    Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: cell movement.
    Detchokul S; Frauman AG
    Br J Pharmacol; 2014 Dec; 171(24):5459-61. PubMed ID: 25442220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical oncology trends].
    Aapro MS
    Rev Med Suisse; 2008 Jan; 4(140):127-38. PubMed ID: 18309876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.